Skip to content

Drug interactions

Deutetrabenazine + Mirabegron

Severity: Moderate

Deutetrabenazine and Mirabegron: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mirabegron is a moderate CYP2D6 inhibitor and can raise exposure to the active metabolites of deutetrabenazine, which are cleared by CYP2D6. Higher exposure may increase dose-related adverse effects such as sedation, depression, parkinsonism and QT prolongation.

What this interaction means in plain words

Deutetrabenazine and Mirabegron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Deutetrabenazine belongs to Central Nervous System; Mirabegron belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Mirabegron inhibits CYP2D6, reducing metabolism of deutetrabenazine's active dihydro-metabolites.

What to do

Titrate deutetrabenazine cautiously and stay within the labeled maximum for CYP2D6 inhibitor use. Monitor for sedation, mood changes, extrapyramidal symptoms and QT effects.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deutetrabenazine and Mirabegron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deutetrabenazine with Mirabegron?

MediHelp rates the interaction as moderate. Deutetrabenazine and Mirabegron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Mirabegron is a moderate CYP2D6 inhibitor and can raise exposure to the active metabolites of deutetrabenazine, which are cleared by CYP2D6. Higher exposure may increase dose-related adverse effects such as sedation, depression, parkinsonism and QT prolongation.

How serious is the interaction between Deutetrabenazine and Mirabegron?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Titrate deutetrabenazine cautiously and stay within the labeled maximum for CYP2D6 inhibitor use. Monitor for sedation, mood changes, extrapyramidal symptoms and QT effects.

What other medicines interact with Mirabegron?

MediHelp also lists interactions of Mirabegron with, for example, Digoxin, Flecainide, Propafenone. The full list is on the Mirabegron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in